Background/aims: Our aims were two-fold: firstly, to investigate the association and interaction between apolipoprotein E (ApoE), lifestyle risk factors and dementia-related mortality and, secondly, to examine if using dementia-related mortality yielded comparable risk estimates for the ApoE genotypes as reported in studies using a clinical dementia diagnosis as the end point.
Methods: We used a nested case-control study with 561 cases drawn from dementia deaths in the Cohort of Norway (CONOR) and 584 alive controls.
Results: ApoE ε4 carriers were at increased risk of dementia-related mortality compared to noncarriers [odds ratio (OR) 2.46, 95% confidence interval (CI) 1.93-3.13], and ε4 homozygotes were at particularly high risk (OR 7.86, 95% CI 3.80-13.8), while the ε2 type was associated with a lower risk. The highest risk of dementia-related mortality was found among ε4 carriers with more lifestyle risk factors (ε4 carriers who were smokers, hypertensive, physically inactive and diabetics) versus ε4 noncarriers without lifestyle risk factors (OR 15.4, 95% CI 4.37-52.4). The increased risk was additive, not multiplicative.
Conclusions: Ensuring a healthy lifestyle is important to be able to prevent dementia in populations at large, but especially for ε4 carriers. Using dementia mortality gives comparable results for the ApoE-dementia association as studies using clinical dementia diagnoses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1159/000431218 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Social patterning of cognitive impairment in Colombia: evidence from the SABE 2015 study.
BMC Geriatr
December 2024
Universidad de los Andes, Escuela de Gobierno Alberto Lleras Camargo, Carrera 1° N° 19-27. Bloque AU, Piso 2, Bogotá, 111711, Colombia.
Introduction: Dementia, an increasingly critical public health concern in low and middle-income countries, is associated with lower socioeconomic status, early cognitive impairment, and elevated dementia-related mortality risk. This study seeks to estimate the prevalence of cognitive impairment, investigate its links with social indicators, and visualize social gradients across different regions in Colombia.
Methods: Secondary data analysis from the SABE 2015 survey, multinomial regression analyses, and equiplot graphs.
Global burden of Alzheimer's disease and other dementias attributed to metabolic risks from 1990 to 2021: results from the global burden of disease study 2021.
BMC Psychiatry
December 2024
School of Management, Shandong Second Medical University, Weifang, 261053, China.
Objective: The risk of Alzheimer's disease (AD) and other dementias increases with greater global exposure to metabolic risks, making this a crucial public health issue. This study aimed to report the metabolism-attributable global burden of AD and other dementias from 1990 to 2021.
Methods: The Global Burden of Disease Study (GBD) 2021 collected data on the number of deaths and disability-adjusted life-years (DALYs) related to AD and other dementias caused by metabolic risks, including high fasting plasma glucose (FPG) and high body mass index (BMI).
Natural history and clinical outcomes in patients with Alzheimer's disease-related psychosis by antipsychotic treatment status in the United States.
J Alzheimers Dis
December 2024
Pharmacoepidemiology and Risk Management, RTI Health Solutions, Research Triangle Park, NC, USA.
Article Synopsis
- The study investigates Alzheimer's disease-related psychosis (ADP) in older adults, focusing on demographic and clinical differences between those treated with antipsychotics and those who are not.
- Researchers analyzed data from over 145,000 ADP patients, comparing health outcomes related to falls, fractures, seizures, and mortality between the two groups.
- Findings reveal that antipsychotic users had more baseline health issues and higher rates of falls, fractures, and mortality compared to nonusers, indicating a significant impact of antipsychotic treatment on health outcomes in ADP patients.
Circulating Ketone Bodies, Pyruvate, and Citrate and Risk of Cognitive Decline, Structural Brain Abnormalities, and Dementia.
Aging Dis
November 2024
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
The relationship between key energy metabolites and brain health is not well understood. We investigated the association between circulating ketone bodies, pyruvate, and citrate with cognitive decline, structural brain characteristics, and risk of dementia. We measured ketone bodies (acetoacetate, β-hydroxybutyrate, and acetone), pyruvate, and citrate species using NMR in plasma samples from 1,850 older adults in the Cardiovascular Health Study collected in 1989-90 or 1992-93.
View Article and Find Full Text PDFEvaluating the Regional and Demographic Variations in Dementia-Related Mortality Trends in the United States: 1999 to 2020.
Int J Geriatr Psychiatry
October 2024
Department of Medicine, King Edward Medical University, Lahore, Pakistan.
Article Synopsis
- Dementia is a growing global healthcare challenge, impacting memory and social abilities while necessitating targeted interventions based on mortality trends and high-risk populations.
- An analysis of CDC WONDER data from 1999-2020 revealed over 4 million dementia-related deaths in the U.S., predominantly from Alzheimer's disease and unspecified dementia, with notable differences in mortality rates based on demographics and geography.
- The age-adjusted mortality rates showed a steep increase from 1999 to 2010, followed by a slower rise until 2020, with females and non-Hispanic whites experiencing the highest rates, while the lowest were found among non-Hispanic Asians or Pacific Islanders.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!